Pelvic Floor Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Pelvic Floor Stimulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Pelvic Floor Stimulation Devices Market By Product Type (Hand-Held, And Fixed), Application (Urinary Incontinence, Pelvic Organ Prolapse, Sexual Dysfunction, And Others), End-User (Hospitals & Clinics, Homecare, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing number of non-invasive treatment for pelvic floor disorders, and rising cases of pelvic floor disorders among others

The pelvic floor stimulation devices market was estimated to grow at CAGR of 5.12% during the forecast period from 2024 to 2030. Several factors drive the demand and adoption of pelvic floor stimulation devices. First, with the increasing cases of pelvic floor disorders such as urinary incontinence, fecal incontinence, pelvic floor prolapse, and others. Also, the growing awareness of pelvic floor disorders and their impact on quality of life prompts individuals to seek solutions like pelvic floor stimulation devices. Factors such as childbirth and lifestyle changes are leading to a higher occurrence of pelvic floor disorders, prompting an escalating need for effective treatment options. Additionally, the preference for non-invasive or minimally invasive treatment options and the expanding geriatric population contribute significantly to market growth during the forecast period from 2024 to 2030.

Pelvic Floor Stimulation Devices Market Dynamics:

According to the data provided by the Continence Foundation of Australia in the year 2022, it was stated that more than one in ten young women experienced bladder leakage (incontinence). Although this could occur in any young woman, female athletes were particularly susceptible. Urinary incontinence, of which stress urinary incontinence (SUI) had a prevalence rate of 25.9% in young female athletes across different sports, with the highest prevalence rate of 75.6% found in volleyball players. Urinary incontinence (UI) was the most common pelvic floor issue affecting women across their lifespan, and its prevalence increased with age. While stress urinary incontinence (SUI) was predominant in younger women, the increasing prevalence of urinary incontinence (UI) presents a significant opportunity for the growth of the pelvic floor stimulation device market. As more women experience UI, especially conditions like stress urinary incontinence (SUI) and overactive bladder (OAB). Pelvic floor stimulation devices offer a solution that can be conveniently used at home, aligning with the growing trend of self-care. Moreover, advancements in technology have made these devices more user-friendly and accessible, with features like smartphone connectivity and personalized treatment plans.

Additionally, as per the projections by the U.S. Census Bureau, the population of Americans aged 100 and older is expected to increase more than four times, from around 101,000 in 2024 to approximately 422,000 by 2054. The growing geriatric population presents a significant opportunity for the expansion of the pelvic floor stimulation device market. With the increasing cases of pelvic floor disorders among older adults and a preference for non-invasive solutions, coupled with technological advancements and professional endorsements, pelvic floor stimulation devices are well-positioned to meet the needs of this demographic and improve their quality of life.

Further, various strategic activities such as acquisitions, approvals, and product launch activities among the market players are also driving the market growth. For example, in July 2022, Renovia Inc. announced that the U.S. Food and Drug Administration (FDA) cleared its leva® Pelvic Health System for the first-line treatment of chronic fecal incontinence (FI) in women.

Therefore all the factors mentioned above are expected to push forward the growth of the pelvic floor stimulation devices market during the forecast of 2024 to 2030.

However, limited accessibility in rural or underdeveloped regions and addressing patient discomfort and embarrassment in pelvic floor device use may hinder the expansion of the overall market for these devices.

Pelvic Floor Stimulation Devices Market Segment Analysis:

Pelvic Floor Stimulation Devices Market by Product Type (Hand-Held and Fixed), Application (Urinary Incontinence, Pelvic Organ Prolapse, Sexual Dysfunction, and Others), End-User (Hospitals & Clinics, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the overall pelvic floor stimulation devices market, the hand-held category is expected to hold the largest share in the year 2023. Hand-held pelvic floor stimulation devices offer essential benefits that blend practicality with therapeutic effectiveness, making them a valuable tool for managing pelvic floor health. Their portable design allows therapy sessions to be conveniently conducted anywhere and at any time, thereby reducing the need for frequent clinic visits and providing flexibility to users. Designed with ease of use in mind, these devices typically feature intuitive controls and ergonomic constructions. This thoughtful design ensures that even individuals without extensive medical training can operate them easily, promoting independence in managing pelvic floor health.

The simplicity of hand-held devices also enhances privacy, enabling discreet management of pelvic floor conditions within the familiar and comfortable setting of one's home. Moreover, their cost-effectiveness plays a pivotal role in improving accessibility to advanced pelvic floor therapy options, making treatment more attainable for a broader demographic. This affordability is particularly beneficial as it lowers barriers to accessing necessary care, ultimately supporting better health outcomes.

As the demand for this segment grows, various novel products are launched by various players operating in the market across the world. For example, in May 2024, Indegene announced the expansion of its partnership with ConTIPI Medical, a provider of non-surgical and disposable solutions for women with various pelvic floor dysfunctions, to bring a new device to the market. ConTIPI’s ProVate was a ready-to-use device that was inserted vaginally by the user into an easy-to-use applicator, very similar to a menstrual tampon. The device had a 510(k) clearance from the FDA for marketing in the US and had been granted the CE mark for marketing in Europe.

Thus, given the various applications and advantages of hand-held pelvic floor stimulation devices, these contributing factors are expected to drive the growth of hand-held pelvic floor stimulation devices, thereby promoting the overall market growth of the pelvic floor stimulation devices market during the forecast period 2024 to 2030.

North America Is Expected To Dominate The Overall Pelvic Floor Stimulation Devices Market:

Among all the regions, North America is expected to hold the largest share of the global Pelvic Floor Stimulation Devices Market in 2023. The market for pelvic floor stimulation devices in North America is expected to grow significantly due to a combination of increasing awareness and education, technological advancements, and the rising prevalence of pelvic floor disorders. Innovative and user-friendly devices, especially those integrating smart technology, will attract more consumers. The aging population and greater focus on postpartum recovery will further boost the market growth of pelvic floor stimulation devices in North America.

According to the latest data from the National Association for Continence (2024), currently, more than 33 million Americans live with urinary incontinence or bladder conditions. Similarly, recent statistics from the Canadian Continence Foundation (2024) show that about 3.3 million Canadians, representing almost 10% of the population, contend with urinary incontinence. Despite the high prevalence rates, there is a notable reluctance among those affected to seek professional medical help. As awareness of UI rises, more individuals will seek medical help and diagnosis, leading to a greater demand for effective treatment options. Patients' preference for non-invasive treatments over surgical alternatives makes pelvic floor stimulation devices particularly attractive. The increasing prevalence of urinary incontinence (UI) in North America is set to significantly drive the growth of the pelvic floor stimulation device market during the forecast period from 2024 to 2030.

Pelvic Floor Stimulation Devices Market Key Players:

Some of the key market players operating in the Pelvic Floor Stimulation Devices Market include Medtronic, OWEN MUMFORD, Myinnovo, Shenzhen XFT Medical Limited, Caldera Medical, ConTIPI Medical Ltd., Laborie, Renovia Inc., Novuqare, GymnaUniphy, InControl Medical, Creo Medical, Axonics, Inc., Verity Medical Ltd, and others.

Recent Developmental Activities In The Pelvic Floor Stimulation Devices Market:

In March 2024, Owen Mumford, a global leader in innovative medical device solutions, announced the acquisition of pelvic floor cushion brand Empelvic, bolstering the company’s pelvic and sexual health portfolio with accessible solutions designed to help consumers treat conditions at their own pace.

In September 2023, Caldera Medical, a women’s health medical device company, announced the completion of its acquisition of Atlantic Therapeutics, a provider of non-invasive pelvic floor strengthening and nerve stimulation solutions for women.

Key Takeaways From The Pelvic Floor Stimulation Devices Market Report Study

Market size analysis for current pelvic floor stimulation devices market size (2023), and market forecast for 6 years (2024 to 2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global pelvic floor stimulation devices market.

Various opportunities available for the other competitors in the pelvic floor stimulation devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current pelvic floor stimulation devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for pelvic floor stimulation devices market growth in the coming future?

Target Audience Who Can Be Benefited From This Pelvic Floor Stimulation Devices Market Report Study

Pelvic Floor Stimulation product providers

Research organizations and consulting companies

Pelvic Floor Stimulation -related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and traders dealing in the pelvic floor stimulation devices market

Various end-users who want to know more about the pelvic floor stimulation devices market and the latest technological developments in the pelvic floor stimulation devices market

Frequently Asked Questions For The Pelvic Floor Stimulation Devices Market:

1.What are pelvic floor stimulation devices?

A pelvic floor stimulation device is a medical device used to treat various pelvic floor disorders by delivering electrical or magnetic stimulation to the pelvic floor muscles. These devices are designed to improve muscle strength, coordination, and function, thereby addressing conditions such as urinary or fecal incontinence, pelvic organ prolapse, pelvic pain, and other related issues.

2. What is the market for the pelvic floor stimulation devices market?

The pelvic floor stimulation devices market was estimated to grow at CAGR of 5.12% during the forecast period from 2024 to 2030.

3. What are the drivers for the pelvic floor stimulation devices market?

Several factors drive the demand and adoption of pelvic floor stimulation devices. First, with the increasing cases of pelvic floor disorders such as urinary incontinence, fecal incontinence, and others. Also, the growing awareness of pelvic floor disorders and their impact on quality of life prompts individuals to seek solutions like pelvic floor stimulation devices. Factors such as childbirth and lifestyle changes are leading to a higher occurrence of pelvic floor disorders, prompting an escalating need for effective treatment options. Technological advancements in these devices enhance their efficacy, patient comfort, and usability, further boosting their adoption. Additionally, the preference for non-invasive or minimally invasive treatment options and the expanding geriatric population contribute significantly to market growth during the forecast period from 2024 to 2030.

4. Who are the key players operating in the pelvic floor stimulation devices market?

Some of the key market players operating in the Pelvic Floor Stimulation Devices Market include Medtronic, OWEN MUMFORD, Myinnovo, Shenzhen XFT Medical Limited, Caldera Medical, ConTIPI Medical Ltd., Laborie, Renovia Inc., Novuqare, GymnaUniphy, InControl Medical, Creo Medical, Axonics, Inc., Verity Medical Ltd, and others.

5. Which region has the highest share in the pelvic floor stimulation devices market?

Among all the regions, North America is expected to hold the largest share of the global Pelvic Floor Stimulation Devices Market in 2023. The market for pelvic floor stimulation devices in North America is expected to grow significantly due to a combination of increasing awareness and education, technological advancements, and the rising prevalence of pelvic floor disorders. Innovative and user-friendly devices, especially those integrating smart technology, will attract more consumers. The aging population and greater focus on postpartum recovery will also drive demand. Favorable reimbursement policies and government support, along with expanding healthcare infrastructure and telehealth services, will improve accessibility. Effective marketing strategies and partnerships, as well as increased investment and research, will further boost the market growth of pelvic floor stimulation devices.